Overexpression of Rit2 in G2019S-LRRK2 neuroblastoma cells restored ALP deficits and reduced accumulation of phosphorylated aSyn (pS129-aSyn), phenocopying the effects of pharmacological LRRK2 kinase inhibition that we recently reported38. The gene discussed is RIT2; the disease is neuroblastoma.